Aya Jakobovits - 03 Jan 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Director
Signature
/s/ Nick Harvey, Attorney-in-Fact for Aya Jakobovits
Issuer symbol
ACET
Transactions as of
03 Jan 2022
Net transactions value
-$396,157
Form type
4
Filing time
14 Feb 2022, 16:28:17 UTC
Previous filing
14 Feb 2022
Next filing
17 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $108,125 -6,000 -1.6% $18.02* 366,343 03 Jan 2022 See Footnote F1, F2, F3
transaction ACET Common Stock Sale $108,131 -6,000 -1.6% $18.02* 366,345 03 Jan 2022 See Footnote F1, F4, F5
transaction ACET Common Stock Sale $33,864 -2,000 -0.55% $16.93* 364,343 05 Jan 2022 See Footnote F1, F3, F6
transaction ACET Common Stock Sale $33,799 -2,000 -0.55% $16.90* 364,345 05 Jan 2022 See Footnote F1, F5, F7
transaction ACET Common Stock Sale $56,118 -4,000 -1.1% $14.03* 360,343 09 Feb 2022 See Footnote F1, F3, F8
transaction ACET Common Stock Sale $56,121 -4,000 -1.1% $14.03* 360,345 09 Feb 2022 See Footnote F1, F5, F9
holding ACET Common Stock 138,076 03 Jan 2022 See Footnote F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F7 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F8 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F9 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F10 Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.